Oncology Information Systems Market, By Application (Radiation Oncology, Medical Oncology, Surgical Oncology), By Product & Service (Software, Service), By End User (Hospital & Oncology Clinic, Research Center), By Region (Asia Pacific, North America, Europe, Middle East & Africa, and South America) – Market Size & Forecasting -2032

The Global Oncology Information Systems Market report includes a global opportunity analysis and industry forecasts for the period 2023-2032. The global market was valued at USD 2.80 Billion in 2022, registering a CAGR of 9.1% from 2023 to 2032. The base year considered for the study is 2021, and the forecast has been provided for the period, 2023 to 2032.

The increasing prevalence of terminal diseases such as cancer has led to a demand for oncology information systems (OIS) for monitoring patient data for treatment delivery. The system meticulously keeps track of information exchange between radiation therapy departments and the overall healthcare enterprise.

The market drivers for the oncology information systems comprise increasing prevalence of cancer worldwide and a progressively increasing geriatric population, which has large number of cancer patients. The multiplying number of cancer therapies has led to the demand for OIS to manage data of rigorous therapies for patients in the healthcare organization. 

Oncology Information Systems Market

COVID-19 IMPACT

With the pandemic showing no signs of abating, during March 2020 and throughout the second quarter of 2020, implementing the oncology information systems diminished as hospitals became primarily focused on the COVID-19 pandemic. It was clear that the pandemic has led to a significant decrease in the demand for oncology information solutions. The pandemic has also affected the oncology field since doctors are not adequately able to concentrate on regular patients since they are being diverted for treating COVID-19 patients. Therefore, performing oncology surgery and therapy has become a challenge with the non-availability of hospital staff and operation facilities. In addition, the oncology information systems market is right on course to come to terms with the losses by the fourth quarter of 2020.      

LATEST TRENDS

The most significant parameters that play a prominent role in the growth of the oncology information systems market comprise benefits of OIS technology in storing records electronically (EHR’s) over manual record keeping. Additionally, new drug formulations for keeping up with new therapies is expected to surge in the coming years.

Additionally, block chain technology is a key driving trend in cancer care that eliminates routine paper work in health records and treatment schedules. Emerging economies are rising in offering market players thriving opportunities during the forecast period.

DRIVING FACTORS

The attributes driving the oncology information systems market include reduced manual errors, low healthcare costs, and easy record keeping with Electronic Health Records (EHR’s). An impressive benefit of healthcare IT Solutions enhances quality of healthcare, which is also expected to assist in treating cancer.

RESTRAINING FACTORS

Absence of skilled manpower and professionals in hospitals and clinics are projected to persist in restricting the market growth during the forecast period.

By Product and Services

Software segment dominates in oncology information system market

By product and services, the oncology information systems market is split into software, and services. The software segment has dominated the market owing to the profound rise in cancer patients globally and the related tests associated with the examination and treatment of cancer patients.  Software products comprise patient information systems, treatment planning systems, and treatment management systems & medical image analysis systems.  

The patient information systems segment was placed second in the oncology information systems market. Rising prevalence of cancer, new product introductions coupled with the rising adoption of web- and cloud-based models, is expected to fuel the growth of this segment during the forecast period.

By Application

Radiation oncology segment to attain largest share in oncology information system market

Based on application, the OIS systems market is fragmented into radiation oncology, medical oncology and surgical oncology.

The radiation oncology segment was largest shareholder in the market. The increasing equipment installation for radiotherapy devices, an ever-growing number of radiosurgery procedures due to rapid growth in number of cancer patients across the globe are driving factors in radiation oncology segment. Furthermore, the development of advanced radiology information systems and radiation treatment planning systems are factors expected to drive the growth of this segment in the forthcoming years.

By End-User

Hospital & oncology clinic segment captures major market share

By end-user, the oncology information systems market is segmented into hospital & oncology clinic, research center.

Amongst these, the hospitals & oncology clinic segment registered the largest share of the market. The large share of this segment is attributed to the large target patient population base (especially in emerging countries) giving their preference for hospitals, the growing patient pool in hospital settings and a rising focus on effective and early disease diagnosis in hospital settings. High budget allocation of hospitals for introducing various technologically advanced oncology information systems is also a motivating factor for the growth of the market.

Regional Insights

North America biggest regional market in overall oncology information systems market

North America is projected to dominate the overall oncology information system market, over the entire forecast period. This is on account of factors such as the rising prevalence of cancer and the access to advanced healthcare infrastructure.

In North America region, the United States is the largest market share holder with rising population suffering from cancer, along with the burgeoning aging population and progressive developments related to cancer therapy.  Rising government initiative for the awareness of cancer in the country is also a propelling factor for growth in this region. These factors are anticipated to further drive the oncology information system market in this region.

Asia Pacific is also anticipated to post the fastest growth due to the high prevalence of cancer coupled with government initiatives and expenditure in the healthcare sector.

Oncology Information Systems Market

KEY DEVELOPMENTS

  • In December 2020, Koninklijke Philips N.V. (Netherlands) launched the advanced Philips IntelliSite Pathology Solution to leverage precision diagnosis for oncology
  • In September 2020, Varian Medical Systems, Inc. (US) was granted FDA approval for the Eclipse v16.1 treatment planning software for cancer therapy.
  • In September 2020, Siemens Healthineers set foot into a definitive agreement to acquire Varian Medical Systems. This acquisition will bolster the company’s currently existing product mix of oncology information systems.

KEY PLAYERS

  • Bogardus Medical Systems, Inc.
  • Cerner Corporation
  • CureMD Corporation
  • Elekta AB
  • Flatiron Health Inc.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • RaySearch Laboratories AB
  • Varian Medical Systems, Inc.

MARKET SEGMENTATION

By Product & Services:

  • Software
  • Service

By Application:

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

By End User:

  • Hospital & Oncology Clinic
  • Research Center

By Region:

North America

  • North America, by Country
    • US
    • Canada
    • Mexico
    • Rest of North America
  • North America, by Product & Service
  • North America, by Application
  • North America, by End User

Europe

  • Europe, by Country
  • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Europe, by Product & Services
  • Europe, by Application
  • Europe, by End User

Asia Pacific

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Asia Pacific, by Product & Services
  • Asia Pacific, by Application
  • Asia Pacific, by End User

Middle East & Africa

  • Middle East & Africa, by Country
    • UAE
    • Saudi Arabia
    • Qatar
    • Rest of Middle East & Africa
  • Middle East, by Product & Services
  • Middle East, by Application
  • Middle East, by End User

South America

  • South America, by Country
    • Brazil
    • Argentina
    • Rest of South America
  • South America, by Products and Services
  • South America, by Application
  • South America, by End User

FAQs Answered in the Report

  • In the global oncology information systems industry, what are the most important regional markets?
  • What is the oncology information systems market segmentation dependent on end-user?
  • What are the major drivers and threats in the global oncology information systems market?
  • What are the profit margins in the oncology information systems industry?

Objectives of this report:

  • To estimate market size for oncology information systems market on regional and global basis.
  • To identify major segments in oncology information systems market and evaluate theirmarket shares and demand.
  • To provide a competitive scenario for the oncology information systems market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of oncology information systems market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the oncology information systems market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the oncology information systems market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com